Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

ACADIA Pharmaceuticals Net Income 2006-2020 | ACAD

For a detailed definition, formula and example for Net Income, check out our new background page here.
ACADIA Pharmaceuticals net income from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
ACADIA Pharmaceuticals Annual Net Income
(Millions of US $)
2020 $-282
2019 $-235
2018 $-245
2017 $-289
2016 $-271
2015 $-164
2014 $-92
2013 $-38
2012 $-21
2011 $-23
2010 $15
2009 $-45
2008 $-64
2007 $-56
2006 $-45
2005 $-34
ACADIA Pharmaceuticals Quarterly Net Income
(Millions of US $)
2020-12-31 $-67
2020-09-30 $-85
2020-06-30 $-42
2020-03-31 $-88
2019-12-31 $-53
2019-09-30 $-42
2019-06-30 $-55
2019-03-31 $-85
2018-12-31 $-65
2018-09-30 $-62
2018-06-30 $-63
2018-03-31 $-54
2017-12-31 $-69
2017-09-30 $-65
2017-06-30 $-67
2017-03-31 $-88
2016-12-31 $-79
2016-09-30 $-72
2016-06-30 $-71
2016-03-31 $-50
2015-12-31 $-46
2015-09-30 $-39
2015-06-30 $-39
2015-03-31 $-40
2014-12-31 $-28
2014-09-30 $-25
2014-06-30 $-21
2014-03-31 $-18
2013-12-31 $-12
2013-09-30 $-11
2013-06-30 $-9
2013-03-31 $-6
2012-12-31 $-7
2012-09-30 $-2
2012-06-30 $-5
2012-03-31 $-6
2011-12-31 $-5
2011-09-30 $-5
2011-06-30 $-7
2011-03-31 $-6
2010-12-31 $29
2010-09-30 $-4
2010-06-30 $-4
2010-03-31 $-5
2009-12-31 $-9
2009-09-30 $-9
2009-06-30 $-13
2009-03-31 $-15
2008-12-31 $-14
2008-09-30 $-16
2008-06-30 $-18
2008-03-31 $-16
2007-12-31 $-17
2007-09-30 $-16
2007-06-30 $-11
2007-03-31 $-13
2006-12-31 $-12
2006-09-30 $-11
2006-06-30 $-12
2006-03-31 $-9
2005-12-31 $-10
2005-09-30 $-12
2005-06-30 $-6
2005-03-31 $-6
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.310B $0.442B
Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.154B 14.87
Bristol Myers Squibb (BMY) United States $138.302B 9.61
CSL (CSLLY) Australia $92.512B 0.00
Gilead Sciences (GILD) United States $81.864B 9.17
Illumina (ILMN) United States $58.906B 89.72
Vertex Pharmaceuticals (VRTX) United States $54.664B 23.24
Moderna (MRNA) United States $53.622B 0.00
Regeneron Pharmaceuticals (REGN) United States $51.033B 16.68
Biogen (BIIB) United States $40.480B 8.10
Alexion Pharmaceuticals (ALXN) United States $33.960B 13.23
BeiGene (BGNE) Cayman Islands $28.810B 0.00
BioNTech SE (BNTX) Germany $27.568B 715.56
Seagen (SGEN) United States $26.193B 44.87
Genmab (GMAB) Denmark $22.037B 30.83
Exact Sciences (EXAS) United States $21.728B 0.00
Genmab (GNMSF) Denmark $21.038B 4.99
Horizon Therapeutics Public (HZNP) Ireland $20.391B 23.39
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.921B 0.00
Incyte (INCY) United States $17.770B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.718B 0.00
Guardant Health (GH) United States $16.020B 0.00
Bio-Techne Corp (TECH) United States $15.719B 90.03
ARGENX SE-ADR (ARGX) Netherlands $14.418B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.225B 113.38
Novavax (NVAX) United States $13.019B 0.00
Zai Lab (ZLAB) China $11.772B 0.00
QIAGEN (QGEN) Netherlands $11.716B 23.90
Repligen (RGEN) United States $11.182B 122.99
CRISPR Therapeutics AG (CRSP) Switzerland $9.080B 0.00
Mirati Therapeutics (MRTX) United States $8.460B 0.00
AbCellera Biologics (ABCL) $8.244B 0.00
Acceleron Pharma (XLRN) United States $7.830B 0.00
Fate Therapeutics (FATE) United States $7.410B 0.00
Exelixis (EXEL) United States $7.288B 66.74
Ultragenyx Pharmaceutical (RARE) United States $7.133B 0.00
Ascendis Pharma (ASND) Denmark $6.961B 0.00
Twist Bioscience (TWST) United States $6.437B 0.00
Denali Therapeutics (DNLI) United States $6.411B 203.81
Halozyme Therapeutics (HALO) United States $6.047B 46.89
Adaptive Biotechnologies (ADPT) United States $5.854B 0.00
Vir Biotechnology (VIR) United States $5.736B 0.00
Sarepta Therapeutics (SRPT) United States $5.675B 0.00
NeoGenomics (NEO) United States $5.603B 683.86
Blueprint Medicines (BPMC) United States $5.453B 17.95
Galapagos (GLPG) Belgium $5.103B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.086B 15.99
Intellia Therapeutics (NTLA) United States $4.949B 0.00
Atea Pharmaceuticals (AVIR) United States $4.699B 0.00
Beam Therapeutics (BEAM) United States $4.674B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $4.400B 0.00
Emergent Biosolutions (EBS) United States $4.188B 10.01
Certara (CERT) United States $4.020B 0.00
Arena Pharmaceuticals (ARNA) United States $4.012B 0.00
Legend Biotech (LEGN) United States $4.001B 0.00
I-Mab (IMAB) China $3.802B 0.00
SpringWorks Therapeutics (SWTX) United States $3.494B 0.00
Reata Pharmaceuticals (RETA) United States $3.434B 0.00
Apellis Pharmaceuticals (APLS) United States $3.340B 0.00
Insmed (INSM) United States $3.338B 0.00
Seer (SEER) $3.268B 0.00
Berkeley Lights (BLI) United States $3.253B 0.00
Arvinas (ARVN) United States $3.149B 0.00
Alkermes (ALKS) Ireland $3.033B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.022B 42.81
MorphoSys AG (MOR) Germany $2.917B 44.34
ALX Oncology Holdings (ALXO) United States $2.896B 0.00
Vericel (VCEL) United States $2.757B 1196.40
Editas Medicine (EDIT) United States $2.746B 0.00
Ligand Pharmaceuticals (LGND) United States $2.586B 48.94
Global Blood Therapeutics (GBT) United States $2.562B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.559B 0.00
Intra-Cellular Therapies (ITCI) United States $2.550B 0.00
Amicus Therapeutics (FOLD) United States $2.450B 0.00
Amarin (AMRN) Ireland $2.361B 0.00
Arcus Biosciences (RCUS) United States $2.190B 0.00
Sorrento Therapeutics (SRNE) United States $2.174B 0.00
Myriad Genetics (MYGN) United States $2.142B 0.00
Bionano Genomics (BNGO) United States $2.098B 0.00
PHARMA MAR SA (PHMMF) Spain $2.070B 0.00
NGM Biopharmaceuticals (NGM) United States $2.025B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.016B 0.00
Morphic Holding (MORF) United States $1.984B 0.00
Revance Therapeutics (RVNC) United States $1.981B 0.00
Bluebird Bio (BLUE) United States $1.938B 0.00
Seres Therapeutics (MCRB) United States $1.882B 0.00
Inovio Pharmaceuticals (INO) United States $1.833B 0.00
Genetron Holdings (GTH) China $1.813B 0.00
Heska (HSKA) United States $1.802B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.779B 0.00
Castle Biosciences (CSTL) United States $1.767B 0.00
Five Prime Therapeutics (FPRX) United States $1.765B 0.00
Cytokinetics (CYTK) United States $1.730B 0.00
Sangamo Therapeutics (SGMO) United States $1.617B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.608B 0.00
UniQure (QURE) Netherlands $1.596B 0.00
Codexis (CDXS) United States $1.586B 0.00
Kymera Therapeutics (KYMR) United States $1.568B 0.00
Immunocore Holdings (IMCR) $1.565B 0.00
Alector (ALEC) United States $1.562B 0.00
Travere Therapeutics (TVTX) United States $1.526B 0.00
REGENXBIO (RGNX) United States $1.495B 0.00
Keros Therapeutics (KROS) United States $1.460B 0.00
C4 Therapeutics (CCCC) United States $1.454B 0.00
Precigen (PGEN) United States $1.452B 0.00
Zymeworks (ZYME) Canada $1.409B 0.00
Nurix Therapeutics (NRIX) United States $1.409B 0.00
Zealand Pharma (ZEAL) Denmark $1.403B 0.00
Cara Therapeutics (CARA) United States $1.370B 343.38
MiMedx (MDXG) United States $1.344B 0.00
Pliant Therapeutics (PLRX) United States $1.307B 0.00
Ocugen (OCGN) United States $1.300B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.240B 0.00
Avid Bioservices (CDMO) United States $1.214B 0.00
Northwest Biotherapeutics (NWBO) United States $1.180B 0.00
Protagonist Therapeutics (PTGX) United States $1.170B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Repare Therapeutics (RPTX) Canada $1.146B 0.00
Shattuck Labs (STTK) United States $1.144B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.139B 0.00
Dynavax Technologies (DVAX) United States $1.129B 0.00
Mersana Therapeutics (MRSN) United States $1.112B 0.00
Mesoblast (MESO) Australia $1.111B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.099B 0.00
Scholar Rock Holding (SRRK) United States $1.090B 0.00
Curis (CRIS) United States $1.083B 0.00
MannKind (MNKD) United States $1.076B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.065B 0.00
G1 THERAPEUTICS (GTHX) United States $1.059B 0.00
Nkarta (NKTX) United States $1.041B 0.00
Coherus BioSciences (CHRS) United States $1.026B 8.34
Arcturus Therapeutics Holdings (ARCT) United States $0.990B 0.00
Sutro Biopharma (STRO) United States $0.976B 0.00
Adverum Biotechnologies (ADVM) United States $0.950B 0.00
Prothena (PRTA) Ireland $0.940B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.912B 38.63
KaloBios Pharmaceuticals (HGEN) United States $0.905B 0.00
Avidity Biosciences (RNA) United States $0.900B 0.00
Merus (MRUS) Netherlands $0.888B 0.00
Cellectis S.A (CLLS) France $0.866B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.863B 0.00
Bolt Biotherapeutics (BOLT) United States $0.860B 0.00
Epizyme (EPZM) United States $0.857B 0.00
Pharming Group (PHAR) Netherlands $0.846B 0.00
Celldex Therapeutics (CLDX) United States $0.832B 0.00
Pharming Group (PHGUF) Netherlands $0.814B 21.67
Adaptimmune Therapeutics (ADAP) United Kingdom $0.798B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.784B 0.00
Inhibrx (INBX) United States $0.777B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.771B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.745B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.730B 0.00
VBI Vaccines (VBIV) United States $0.729B 0.00
IDEAYA Biosciences (IDYA) United States $0.702B 0.00
Affimed (AFMD) Germany $0.697B 0.00
Clovis Oncology (CLVS) United States $0.688B 0.00
Adagene (ADAG) $0.686B 0.00
Cel-Sci (CVM) United States $0.663B 0.00
Starpharma Holdings (SPHRY) Australia $0.662B 0.00
Kadmon Holdings (KDMN) United States $0.661B 0.00
DBV Technologies S.A (DBVT) France $0.652B 0.00
ChromaDex (CDXC) United States $0.646B 0.00
ALBIREO PHARMA (ALBO) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Xenon Pharmaceuticals (XENE) Canada $0.623B 0.00
MeiraGTx Holdings (MGTX) United States $0.610B 0.00
AnaptysBio (ANAB) United States $0.607B 0.00
Anika Therapeutics (ANIK) United States $0.580B 192.76
Compugen (CGEN) Israel $0.576B 0.00
Agenus (AGEN) United States $0.571B 0.00
Inventiva S.A (IVA) France $0.570B 0.00
RAPT THERAPTICS (RAPT) United States $0.550B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.539B 0.00
AMMO (POWW) United States $0.522B 0.00
Neoleukin Therapeutics (NLTX) United States $0.511B 0.00
Forte Biosciences (FBRX) United States $0.508B 0.00
Precision BioSciences (DTIL) United States $0.508B 0.00
CytomX Therapeutics (CTMX) United States $0.506B 0.00
Amryt Pharma (AMYT) United Kingdom $0.504B 0.00
XBiotech (XBIT) United States $0.498B 0.00
AC Immune SA (ACIU) Switzerland $0.497B 0.00
Geron (GERN) United States $0.484B 0.00
Verastem (VSTM) United States $0.482B 0.00
Selecta Biosciences (SELB) United States $0.481B 0.00
AquaBounty Technologies (AQB) United States $0.475B 0.00
Fortress Biotech (FBIO) United States $0.463B 0.00
Angion Biomedica (ANGN) United States $0.463B 0.00
Gritstone Oncology (GRTS) United States $0.452B 0.00
Kala Pharmaceuticals (KALA) United States $0.447B 0.00
XOMA (XOMA) United States $0.442B 98.25
SESEN BIO, INC (SESN) United States $0.440B 0.00
Seelos Therapeutics (SEEL) United States $0.428B 0.00
Opthea (OPT) Australia $0.425B 0.00
Syros Pharmaceuticals (SYRS) United States $0.422B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.413B 0.00
Athersys (ATHX) United States $0.411B 0.00
Adicet Bio (ACET) United States $0.409B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.409B 0.00
UROGEN PHARMA (URGN) United States $0.406B 0.00
Athenex (ATNX) United States $0.401B 0.00
ANI Pharmaceuticals (ANIP) United States $0.395B 11.02
Spero Therapeutics (SPRO) United States $0.395B 0.00
Oncobiologics (OTLK) United States $0.391B 0.00
Fulcrum Therapeutics (FULC) United States $0.389B 0.00
Puma Biotechnology (PBYI) United States $0.380B 0.00
Cue Biopharma (CUE) United States $0.378B 0.00
SQZ Biotechnologies (SQZ) United States $0.377B 0.00
CorMedix Inc (CRMD) United States $0.373B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.369B 0.00
BioDelivery Sciences (BDSI) United States $0.368B 14.60
Frequency Therapeutics (FREQ) United States $0.367B 0.00
HOOKIPA Pharma (HOOK) United States $0.358B 0.00
Cardiff Oncology (CRDF) United States $0.356B 0.00
Theratechnologies (THTX) Canada $0.353B 0.00
Innate Pharma S.A (IPHA) France $0.344B 0.00
Bellus Health (BLU) Canada $0.336B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.327B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.326B 0.00
IBio (IBIO) United States $0.324B 0.00
Codiak BioSciences (CDAK) United States $0.320B 0.00
Kaleido Biosciences (KLDO) $0.319B 0.00
Arbutus Biopharma (ABUS) United States $0.314B 0.00
Cogent Biosciences (COGT) United States $0.310B 0.00
WAVE Life Sciences (WVE) Singapore $0.308B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.303B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.291B 0.00
Trevena (TRVN) United States $0.290B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Kamada (KMDA) Israel $0.275B 15.82
NextCure (NXTC) United States $0.271B 0.00
Cerecor (CERC) United States $0.265B 0.00
OVID THERAPEUTC (OVID) United States $0.243B 0.00
Protalix BioTherapeutics (PLX) Israel $0.235B 0.00
Prima BioMed (IMMP) Australia $0.230B 0.00
ADMA Biologics Inc (ADMA) United States $0.227B 0.00
Checkpoint Therapeutics (CKPT) United States $0.225B 0.00
VTv Therapeutics (VTVT) United States $0.219B 0.00
Kindred Biosciences (KIN) United States $0.208B 0.00
LogicBio Therapeutics (LOGC) United States $0.203B 0.00
OSMOTICA PHARM (OSMT) United States $0.203B 0.00
Aptinyx (APTX) United States $0.199B 0.00
TELA Bio (TELA) United States $0.198B 0.00
Applied Genetic Technologies (AGTC) United States $0.195B 0.00
POXEL SA FRANCE (PXXLF) France $0.193B 0.00
VolitionRX (VNRX) United States $0.190B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.190B 0.00
Exicure (XCUR) United States $0.186B 0.00
Strongbridge Biopharma (SBBP) United States $0.181B 0.00
Voyager Therapeutics (VYGR) United States $0.180B 5.02
ObsEva SA (OBSV) Switzerland $0.180B 0.00
GENFIT S.A (GNFT) France $0.179B 0.00
Antibe Therapeutics (ATBPF) Canada $0.178B 0.00
DiaMedica Therapeutics (DMAC) United States $0.177B 0.00
Eton Pharmaceuticals (ETON) United States $0.176B 0.00
Nicox SA (NICXF) France $0.176B 0.00
Chiasma (CHMA) United States $0.175B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.171B 0.00
INmune Bio (INMB) United States $0.170B 0.00
Enzo Biochem (ENZ) United States $0.168B 0.00
Abeona Therapeutics (ABEO) United States $0.165B 0.00
X4 Pharmaceuticals (XFOR) United States $0.164B 0.00
Catalyst Biosciences (CBIO) United States $0.162B 0.00
Biofrontera AG (BFRA) Germany $0.158B 0.00
Pluristem Therapeutics (PSTI) Israel $0.151B 0.00
Palatin Technologies (PTN) United States $0.150B 0.00
Eyenovia (EYEN) United States $0.147B 0.00
Clearside Biomedical (CLSD) United States $0.146B 0.00
Evofem Biosciences (EVFM) United States $0.146B 0.00
Erytech Pharma SA (ERYP) France $0.146B 0.00
Dyadic (DYAI) United States $0.144B 0.00
Novogen (KZIA) Australia $0.139B 0.00
TRACON Pharmaceuticals (TCON) United States $0.139B 0.00
Galena Biopharma (SLS) United States $0.137B 0.00
Orgenesis (ORGS) United States $0.134B 274.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.133B 0.00
Synlogic (SYBX) United States $0.132B 0.00
Zosano Pharma (ZSAN) United States $0.130B 0.00
Aytu BioPharma (AYTU) United States $0.128B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.126B 0.00
Evogene (EVGN) Israel $0.125B 0.00
Beyond Air (XAIR) United States $0.124B 0.00
Liminal BioSciences (LMNL) Canada $0.124B 0.00
Aptevo Therapeutics (APVO) United States $0.119B 0.00
Cidara Therapeutics (CDTX) United States $0.115B 0.00
ARAVIVE, INC (ARAV) United States $0.115B 0.00
Armata Pharmaceuticals (ARMP) United States $0.115B 0.00
Liquidia Technologies (LQDA) United States $0.110B 0.00
Leap Therapeutics (LPTX) United States $0.109B 0.00
Celsion (CLSN) United States $0.106B 0.00
Cocrystal Pharma (COCP) United States $0.106B 0.00
Ecology Coatings (ABVC) United States $0.103B 0.00
Celyad SA (CYAD) Belgium $0.100B 0.00
Lumos Pharma (LUMO) United States $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Cyclerion Therapeutics (CYCN) United States $0.097B 0.00
AIkido Pharma (AIKI) United States $0.096B 0.00
Vascular Biogenics (VBLT) Israel $0.092B 0.00
Cleveland BioLabs (CBLI) United States $0.092B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.086B 0.00
Advaxis (ADXS) United States $0.085B 0.00
CytRx (CYTR) United States $0.084B 0.00
Vaccinex (VCNX) United States $0.080B 0.00
Timber Pharmaceuticals (TMBR) United States $0.078B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
Edesa Biotech (EDSA) Canada $0.075B 0.00
Pulmatrix (PULM) United States $0.074B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
BioCardia (BCDA) United States $0.072B 0.00
Organovo Holdings (ONVO) United States $0.069B 0.00
ATyr Pharma (LIFE) United States $0.069B 0.00
AEterna Zentaris (AEZS) United States $0.068B 0.00
Purple Biotech (PPBT) Israel $0.067B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.065B 0.00
Windtree Therapeutics (WINT) United States $0.065B 0.00
Genetic Technologies (GENE) Australia $0.064B 0.00
ARIDIS PHARMACT (ARDS) United States $0.063B 0.00
AnPac Bio-Medical Science (ANPC) China $0.063B 0.00
Soligenix (SNGX) United States $0.062B 0.00
ZIVO Bioscience (ZIVO) United States $0.061B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.058B 0.00
Idera Pharmaceuticals (IDRA) United States $0.057B 0.00
Enveric Biosciences (ENVB) United States $0.057B 0.00
Alimera Sciences (ALIM) United States $0.054B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.054B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.054B 0.00
Happiness Biotech Group (HAPP) China $0.053B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Yumanity Therapeutics (YMTX) United States $0.049B 0.00
Cyclo Therapeutics (CYTH) United States $0.048B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.046B 0.00
Clene (CLNN) Hong Kong, SAR China $0.044B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.63
Sonnet BioTherapeutics Holdings (SONN) United States $0.041B 0.00
IMMURON (IMRN) Australia $0.034B 0.00
ThermoGenesis Holdings (THMO) United States $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
Seneca Biopharma (SNCA) United States $0.032B 0.00
Vallon Pharmaceuticals (VLON) United States $0.031B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.026B 0.00
Benitec Biopharma (BNTC) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Invo BioScience (INVO) United States $0.020B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.008B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
China Biologic Products (CBPO) China $0.000B 29.35
Entera Bio (ENTX) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00